References
- Adler, L., Pachtman, E., Franks, R., Pecevich, M., Waldo, M., & Freedman, R. (1982). Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry, 17(6), 639–654.
- Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological Reviews, 89(1), 73–120. https://pubmed.ncbi.nlm.nih.gov/19126755/ doi: 10.1152/physrev.00015.2008.
- Audrain-McGovern, J., Lerman, C., Wileyto, E. P., Rodriguez, D., & Shields, P. G. (2004). Interacting effects of genetic predisposition and depression on adolescent smoking progression. The American Journal of Psychiatry, 161(7), 1224–1230. https://pubmed.ncbi.nlm.nih.gov/15229055/ doi: 10.1176/appi.ajp.161.7.1224.
- Baer, J. S., Kamarck, T., Lichtenstein, E., & Ransom, C. C. (1989). Prediction of smoking relapse: analyses of temptations and transgressions after initial cessation. Journal of Consulting and Clinical Psychology, 57(5), 623–627. doi: 10.1037//0022-006x.57.5.623.
- Beckham, J. C., Lytle, B. L., Vrana, S. R., Hertzberg, M. A., Feldman, M. E., & Shipley, R. H. (1996). Smoking withdrawal symptoms in response to a trauma-related stressor among Vietnam combat veterans with posttraumatic stress disorder. Addictive Behaviors, 21(1), 93–101. https://pubmed.ncbi.nlm.nih.gov/8729711/ doi: 10.1016/0306-4603(95)00038-0.
- Bencherif, M., & Schmitt, J. D. (2002). Targeting neuronal nicotinic receptors: a path to new therapies. Current Drug Targets. CNS and Neurological Disorders, 1(4), 349–357. https://pubmed.ncbi.nlm.nih.gov/12769609/ doi: 10.2174/1568007023339094.
- Boden, J. M., Fergusson, D. M., & Horwood, L. J. (2010). Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort. The British Journal of Psychiatry, 196(6), 440–446. https://pubmed.ncbi.nlm.nih.gov/20513853/ doi: 10.1192/bjp.bp.109.065912.
- Bortolasci, C. C., Vargas, H. O., Souza-Nogueira, A., Barbosa, D. S., Moreira, E. G., Nunes, S. O. V., Berk, M., Dodd, S., & Maes, M. (2014). Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. Journal of Affective Disorders, 159, 23–30. https://pubmed.ncbi.nlm.nih.gov/24679385/ doi: 10.1016/j.jad.2014.02.018.
- Brandon, T. H. (1994). Negative affect as motivation to smoke. Current Directions in Psychological Science, 3(2), 33–37. doi: 10.1111/1467-8721.ep10769919.
- Breslau, N., & Johnson, E. O. (2000). Predicting smoking cessation and major depression in nicotine-dependent smokers. American Journal of Public Health, 90(7), 1122–1127. https://pubmed.ncbi.nlm.nih.gov/10897192/
- Breslau, N., & Klein, D. F. (1999). Smoking and panic attacks: an epidemiologic investigation. Archives of General Psychiatry, 56(12), 1141–1147. https://pubmed.ncbi.nlm.nih.gov/10591292/ doi: 10.1001/archpsyc.56.12.1141.
- Breslau, N., Kilbey, M. M., & Andreski, P. (1991). Nicotine dependence, major depression, and anxiety in young adults. Archives of General Psychiatry, 48(12), 1069–1074. https://pubmed.ncbi.nlm.nih.gov/1845224/ doi: 10.1001/archpsyc.1991.01810360033005.
- Breslau, N., Kilbey, M. M., & Andreski, P. (1993). Vulnerability to psychopathology in nicotine-dependent smokers: an epidemiologic study of young adults. The American Journal of Psychiatry, 150(6), 941–946. https://pubmed.ncbi.nlm.nih.gov/8494073/
- Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998). Major depression and stages of smoking. A longitudinal investigation. Archives of General Psychiatry, 55(2), 161–166. https://pubmed.ncbi.nlm.nih.gov/9477930/ doi: 10.1001/archpsyc.55.2.161.
- Brown, R. A., Kahler, C. W., Niaura, R., Abrams, D. B., Sales, S. D., Ramsey, S. E., Goldstein, M. G., Burgess, E. S., & Miller, I. W. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology, 69(3), 471–480. https://pubmed.ncbi.nlm.nih.gov/11495176/ doi: 10.1037//0022-006x.69.3.471.
- Brown, R. A., Lewinsohn, P. M., Seeley, J. R., & Wagner, E. F. (1996). Cigarette smoking, major depression, and other psychiatric disorders among adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 35(12), 1602–1610. doi: 10.1097/00004583-199612000-00011.
- Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Diaz, M., & Braff, D. L. (2000). Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. The American Journal of Psychiatry, 157(10), 1660–1668. https://pubmed.ncbi.nlm.nih.gov/11007721/ doi: 10.1176/appi.ajp.157.10.1660.
- Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019). Psychiatric comorbidities in alcohol use disorder. The Lancet. Psychiatry, 6(12), 1068–1080. doi: 10.1016/S2215-0366(19)30222-6.
- Chaiton, M. O., Cohen, J. E., O’Loughlin, J., & Rehm, J. (2009). A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC Public Health [Internet], 9(1), 356. doi: 10.1186/1471-2458-9-356.
- Chambers, R. A. (2009). A nicotine challenge to the self-medication hypothesis in a neurodevelopmental animal model of schizophrenia. Journal of Dual Diagnosis, 5(2), 139–148. https://pubmed.ncbi.nlm.nih.gov/20556221/ doi: 10.1080/15504260902869808.
- Changeux, J. P. (2010). Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nature Reviews. Neuroscience, 11(6), 389–401. https://www.nature.com/articles/nrn2849 doi: 10.1038/nrn2849.
- Chen, X. S., Li, C. B., Smith, R. C., Xiao, Z. P., & Wang, J. J (2011). Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients. Psychiatry Research, 188(3), 327–333. https://pubmed.ncbi.nlm.nih.gov/21216472/ doi: 10.1016/j.psychres.2010.12.009.
- Cougle, J. R., Keough, M. E., Riccardi, C. J., & Sachs-Ericsson, N. (2009). Anxiety disorders and suicidality in the national comorbidity survey-replication. Journal of Psychiatric Research, 43(9), 825–829. doi: 10.1016/j.jpsychires.2008.12.004.
- Covey, L. S., Glassman, A. H., & Stetner, F. (1997). Major depression following smoking cessation. The American Journal of Psychiatry. 154(2), 263–265. https://pubmed.ncbi.nlm.nih.gov/9016279/
- De Luca, V., Wong, A. H. C., Muller, D. J., Wong, G. W. H., Tyndale, R. F., & Kennedy, J. L. (2004). Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology, 29(8), 1522–1526. https://pubmed.ncbi.nlm.nih.gov/15100704/ doi: 10.1038/sj.npp.1300466.
- D’Souza, M. S., & Markou, A. (2013). The “stop” and “go” of nicotine dependence: role of gaba and glutamate. Cold, Spring Harb Perspect Med. 3(6), a012146.
- Etkin, A., Prater, K. E., Schatzberg, A. F., Menon, V., & Greicius, M. D. (2009). Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Archives of General Psychiatry, 66(12), 1361–1372. https://pubmed.ncbi.nlm.nih.gov/19996041/ doi: 10.1001/archgenpsychiatry.2009.104.
- Fluharty, M., Taylor, A. E., Grabski, M., & Munafò, M. R. (2017). The association of cigarette smoking with depression and anxiety: A systematic review. Nicotine & Tobacco Research, 19(1), 3–13. https://pubmed.ncbi.nlm.nih.gov/27199385/ doi: 10.1093/ntr/ntw140.
- Garey, L., Olofsson, H., Garza, T., Shepherd, J. M., Smit, T., & Zvolensky, M. J. (2020). The role of anxiety in smoking onset, severity, and cessation-related outcomes: a review of recent literature. Current Psychiatry Reports, 22(8), 38. https://pubmed.zncbi.nlm.nih.gov/32506166/ doi: 10.1007/s11920-020-01160-5.
- George, T. P., & Ziedonis, D. M. (2009). Addressing tobacco dependence in psychiatric practice: promises and pitfalls. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 54(6), 353–355. https://pubmed.ncbi.nlm.nih.gov/19527555/ doi: 10.1177/070674370905400602.
- Goff, D. C., & Coyle, J. T. (2001). [cited 2023 May 2] The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. The American Journal of Psychiatry, 158(9), 1367–1377. https://pubmed.ncbi.nlm.nih.gov/11532718/ doi: 10.1176/appi.ajp.158.9.1367.
- Golier, J., & Yehuda, R. (2002). Neuropsychological processes in post-traumatic stress disorder. The Psychiatric Clinics of North America, 25(2), 295–315, vi. https://pubmed.ncbi.nlm.nih.gov/12136502/ doi: 10.1016/S0193-953X(01)00004-1.
- Gonzalez, M. d O., Goudriaan, A. E., Périco, C. d A.-M., Waisman Campos, M., de Andrade, A. G., Bhugra, D., & Castaldelli-Maia, J. M. (2017). Neural correlates of depressive symptoms in smokers – A systematic review of imaging studies. Substance Use & Misuse, 52(14), 1809–1822. Available from: https://pubmed.ncbi.nlm.nih.gov/28742414/ doi: 10.1080/10826084.2017.1312447.
- Gotti, C., Zoli, M., & Clementi, F. (2006). Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends in Pharmacological Sciences, 27(9), 482–491. https://pubmed.ncbi.nlm.nih.gov/16876883/ doi: 10.1016/j.tips.2006.07.004.
- Greenwood, P. M., Parasuraman, R., & Espeseth, T. (2012). A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4. Neuroscience and Biobehavioral Reviews, 36(4), 1331–1341. https://pubmed.ncbi.nlm.nih.gov/22373960/ doi: 10.1016/j.neubiorev.2012.02.010.
- Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004). Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. Journal of Consulting and Clinical Psychology, 72(4), 563–570. doi: 10.1037/0022-006X.72.4.563.
- Hahad, O., Daiber, A., Michal, M., Kuntic, M., Lieb, K., Beutel, M., & Münzel, T. (2021). Smoking and neuropsychiatric disease—Associations and underlying mechanisms. International Journal of Molecular Sciences, 22(14), a012146. doi: 10.3390/ijms22147272.
- Hamilton, H. K., D’Souza, D. C., Ford, J. M., Roach, B. J., Kort, N. S., Ahn, K.-H., Bhakta, S., Ranganathan, M., & Mathalon, D. H. (2018). Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. Schizophrenia Research, 191, 87–94. https://pubmed.ncbi.nlm.nih.gov/28711472/ doi: 10.1016/j.schres.2017.06.040.
- Hay, R. A., Roach, B. J., Srihari, V. H., Woods, S. W., Ford, J. M., & Mathalon, D. H. (2015). Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients. Biological Psychology, 105, 130–137. https://pubmed.ncbi.nlm.nih.gov/25603283/ doi: 10.1016/j.biopsycho.2015.01.004.
- Hong, L. E., Wonodi, I., Lewis, J., & Thaker, G. K. (2008). Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology, 33(9), 2167–2174. doi: 10.1038/sj.npp.1301601.
- Houy, E., Raux, G., Thibaut, F., Belmont, A., Demily, C., Allio, G., Haouzir, S., Fouldrin, G., Petit, M., Frebourg, T., & Campion, D. (2004). The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit. Molecular Psychiatry, 9(3), 320–322. https://pubmed.ncbi.nlm.nih.gov/14569275/ doi: 10.1038/sj.mp.4001443.
- Hutchison, K. E., Allen, D. L., Filbey, F. M., Jepson, C., Lerman, C., Benowitz, N. L., Stitzel, J., Bryan, A., McGeary, J., & Haughey, H. M. (2007). CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Archives of General Psychiatry, 64(9), 1078–1086. https://pubmed.ncbi.nlm.nih.gov/17768273/ doi: 10.1001/archpsyc.64.9.1078.
- Ishikawa, M., & Hashimoto, K. (2011). α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. Current Pharmaceutical Design, 17(2), 121–129. https://pubmed.ncbi.nlm.nih.gov/21355839/ doi: 10.2174/138161211795049561.
- Johnson, J. G., Cohen, P., Pine, D. S., Klein, D. F., Kasen, S., & Brook, J. S. (2000). Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA [Internet], 284(18), 2348–2351. https://pubmed.ncbi.nlm.nih.gov/11066185/ doi: 10.1001/jama.284.18.2348.
- Keyes, K. M., Eaton, N. R., Krueger, R. F., Skodol, A. E., Wall, M. M., Grant, B., Siever, L. J., & Hasin, D. S. (2013). Thought disorder in the meta-structure of psychopathology. Psychological Medicine, 43(8), 1673–1683. doi: 10.1017/S0033291712002292.
- Kunas, S. L., Hilbert, K., Yang, Y., Richter, J., Hamm, A., Wittmann, A., Ströhle, A., Pfleiderer, B., Herrmann, M. J., Lang, T., Lotze, M., Deckert, J., Arolt, V., Wittchen, H.-U., Straube, B., Kircher, T., Gerlach, A. L., & Lueken, U. (2020). The modulating impact of cigarette smoking on brain structure in panic disorder: a voxel-based morphometry study. Social Cognitive and Affective Neuroscience, 15(8), 849–859. doi: 10.1093/scan/nsaa103.
- Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A population-based prevalence study. JAMA, 284(20), 2606–2610. https://jamanetwork.com/journals/jama/fullarticle/193305 doi: 10.1001/jama.284.20.2606.
- Lee, M., Sehatpour, P., Hoptman, M. J., Lakatos, P., Dias, E. C., Kantrowitz, J. T., Martinez, A. M., & Javitt, D. C. (2017). Neural mechanisms of mismatch negativity dysfunction in schizophrenia. Molecular Psychiatry, 22(11), 1585–1593. https://pubmed.ncbi.nlm.nih.gov/28167837/ doi: 10.1038/mp.2017.3.
- Leonard, S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C., Berger, R., Venn, D., Sirota, P., Zerbe, G., Olincy, A., Ross, R. G., Adler, L. E., & Freedman, R. (2002). Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Archives of General Psychiatry, 59(12), 1085–1096. https://pubmed.ncbi.nlm.nih.gov/12470124/ doi: 10.1001/archpsyc.59.12.1085.
- Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N. R., Bowman, E. D., & Shields, P. G. (1998). Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychology, 17(1), 56–62. doi: 10.1037//0278-6133.17.1.56.
- Lewis, A., Miller, J. H., & Lea, R. A. (2007). Monoamine oxidase and tobacco dependence. Neurotoxicology, 28(1), 182–195. doi: 10.1016/j.neuro.2006.05.019.
- Li, X., Semenova, S., D’Souza, M. S., Stoker, A. K., & Markou, A. (2014). Involvement of glutamatergic and GABAergic systems in nicotine dependence: implications for novel pharmacotherapies for smoking cessation. Neuropharmacology, 76 Pt B(0 0), 554–565. doi: 10.1016/j.neuropharm.2013.05.042.
- Light, G. A., & Näätänen, R. (2013). Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders. Proceedings of the National Academy of Sciences of the United States of America, 110(38), 15175–15176. doi: 10.1073/pnas.1313287110.
- Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K., & George, T. P. (2018). Neurobiological determinants of tobacco smoking in schizophrenia. Frontiers in Psychiatry, 9, 672. doi: 10.3389/fpsyt.2018.00672.
- Lyons, M., Hitsman, B., Xian, H., Panizzon, M. S., Jerskey, B. A., Santangelo, S., Grant, M. D., Rende, R., Eisen, S., Eaves, L., & Tsuang, M. T. (2008). A twin study of smoking, nicotine dependence, and major depression in men. Nicotine & Tobacco Research, 10(1), 97–108. https://pubmed.ncbi.nlm.nih.gov/18188750/ doi: 10.1080/14622200701705332.
- Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology, 18(3), 135–174. https://pubmed.ncbi.nlm.nih.gov/9471114/ doi: 10.1016/S0893-133X(97)00113-9.
- Mccabe, R. E., Chudzik, S. M., Antony, M. M., Young, L., Swinson, R. P., & Zolvensky, M. J. (2004). Smoking Behaviors across Anxiety Disorders.Journal of Anxiety Disorders, 18(1):7–18. doi: 10.1016/j.janxdis.2003.07.003.
- Menossi, H. S., Goudriaan, A. E., de Azevedo-Marques Périco, C., Nicastri, S., de Andrade, A. G., D’Elia, G., Li, C.-S R., & Castaldelli-Maia, J. M. (2013). Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review. CNS Drugs [Internet], 27(11), 921–941. https://pubmed.ncbi.nlm.nih.gov/23853032/ doi: 10.1007/s40263-013-0092-8.
- Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. (2010). Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. Journal of Molecular Neuroscience : MN, 40(1-2), 185–195. https://pubmed.ncbi.nlm.nih.gov/19680823/ doi: 10.1007/s12031-009-9233-4.
- Morisano, D., Wing, V. C., Sacco, K. A., Arenovich, T., & George, T. P. (2013). Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. The American Journal on Addictions, 22(1), 46–53. https://pubmed.ncbi.nlm.nih.gov/23398226/ doi: 10.1111/j.1521-0391.2013.00313.x.
- Morissette, S. B., Tull, M. T., Gulliver, S. B., Kamholz, B. W., & Zimering, R. T. (2007). Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychological Bulletin, 133(2), 245–272. ://pubmed.ncbi.nlm.nih.gov/17338599/ doi: 10.1037/0033-2909.133.2.245.
- Munafò, M. R., & Araya, R. (2010). Jun [cited 2023 May 2] Cigarette smoking and depression: a question of causation. The British Journal of Psychiatry, 196(6), 425–426. https://pubmed.ncbi.nlm.nih.gov/20513848/ doi: 10.1192/bjp.bp.109.074880.
- Olincy, A., Braff, D. L., Adler, L. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., Light, G. A., Mintz, J., Nuechterlein, K. H., Radant, A. D., Schork, N. J., Seidman, L. J., Siever, L. J., Silverman, J. M., Stone, W. S., … Freedman, R. (2010). Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the consortium on genetics of schizophrenia. schizophrenia research, 119(1-3), 175–182. doi: 10.1016/j.schres.2010.03.004.
- ONS - Office for National Statistics. Adult smoking habits in the UK - Office for National Statistics [Internet]. 2020 [cited 2023 May 2]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/bulletins/adultsmokinghabitsingreatbritain/2019
- Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003). Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Experimental and Clinical Psychopharmacology, 11(4), 276–285. https://pubmed.ncbi.nlm.nih.gov/14599261/ doi: 10.1037/1064-1297.11.4.276.
- Picciotto, M. R., & Corrigall, W. A. (2002). Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. The Journal of Neuroscience, 22(9), 3338–3341. https://pubmed.ncbi.nlm.nih.gov/11978809/ doi: 10.1523/JNEUROSCI.22-09-03338.2002.
- Picciotto, M. R., Caldarone, B. J., King, S. L., & Zachariou, V. (2000). Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology, 22(5), 451–465. https://www.nature.com/articles/1395470 doi: 10.1016/S0893-133X(99)00146-3.
- Pomerleau, O. F., Turk, D. C., & Fertig, J. B. (1984). The effects of cigarette smoking on pain and anxiety. Addictive Behaviors, 9(3), 265–271. https://pubmed.ncbi.nlm.nih.gov/6496202/ doi: 10.1016/0306-4603(84)90018-2.
- RCP, RCPSYCH. Smoking and mental health. London; 2013. www.rcplondon.ac.uk
- Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002). Nicotinic-serotonergic interactions in brain and behaviour. Pharmacology, Biochemistry, and Behavior, 71(4), 795–805. https://pubmed.ncbi.nlm.nih.gov/11888570/ doi: 10.1016/S0091-3057(01)00715-8.
- Spanakis, P., Peckham, E., Young, B., Heron, P., Bailey, D., & Gilbody, S. (2022). A systematic review of behavioural smoking cessation interventions for people with severe mental ill health—what works? Addiction, 117(6), 1526–1542. doi: 10.1111/add.15724.
- Stephens, S. H., Logel, J., Barton, A., Franks, A., Schultz, J., Short, M., Dickenson, J., James, B., Fingerlin, T. E., Wagner, B., Hodgkinson, C., Graw, S., Ross, R. G., Freedman, R., & Leonard, S. (2009). Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophrenia Research, 109(1-3), 102–112. doi: 10.1016/j.schres.2008.12.017.
- Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014). Feb 13 Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ (Clinical Research ed.), 348, g1151. https://pubmed.ncbi.nlm.nih.gov/24524926/ doi: 10.1136/bmj.g1151.
- Umbricht, D., Koller, R., Vollenweider, F. X., & Schmid, L. (2002). Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biological Psychiatry, 51(5), 400–406. https://pubmed.ncbi.nlm.nih.gov/11904134/ doi: 10.1016/s0006-3223(01)01242-2.
- Windle, M., & Windle, R. C. (2001). Depressive symptoms and cigarette smoking among middle adolescents: Prospective associations and intrapersonal and interpersonal influences. Journal of Consulting and Clinical Psychology, 69(2), 215–226. doi: 10.1037/0022-006X.69.2.215.
- Wing, V. C., Bacher, I., Sacco, K. A., & George, T. P. (2011). Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Psychiatry Research, 188(3), 320–326. https://pubmed.ncbi.nlm.nih.gov/21669462/ doi: 10.1016/j.psychres.2011.05.037.
- Wing, V. C., Wass, C. E., Soh, D. W., & George, T. P. (2012). A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Annals of the New York Academy of Sciences, 1248(1), 89–106. https://pubmed.ncbi.nlm.nih.gov/22129082/ doi: 10.1111/j.1749-6632.2011.06261.x.
- Winterer, G. (2010). Why do patients with schizophrenia smoke? Current Opinion in Psychiatry, 23(2), 112–119. https://journals.lww.com/co-psychiatry/Fulltext/2010/03000/Why_do_patients_with_schizophrenia_smoke_.7.aspx doi: 10.1097/YCO.0b013e3283366643.
- Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., Calhoun, P. S., & Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco, 10(12), 1691–1715. https://pubmed.ncbi.nlm.nih.gov/19023823/ doi: 10.1080/14622200802443569.
- Zoli, M., Pistillo, F., & Gotti, C. (2015). Diversity of native nicotinic receptor subtypes in mammalian brain. Neuropharmacology, 96(Pt B), 302–311. https://pubmed.ncbi.nlm.nih.gov/25460185/ doi: 10.1016/j.neuropharm.2014.11.003.
- Zvolensky, M. J., Feldner, M. T., Leen-Feldner, E. W., & McLeish, A. C. (2005). Smoking and panic attacks, panic disorder, and agoraphobia: A review of the empirical literature. Clinical Psychology Review, 25(6), 761–789. doi: 10.1016/j.cpr.2005.05.001.
- Zvolensky, M. J., Kotov, R., Antipova, A. V., & Schmidt, N. B. (2003). Cross cultural evaluation of smokers risk for panic and anxiety pathology: a test in a Russian epidemiological sample. Behaviour Research and Therapy, 41(10), 1199–1215. doi: 10.1016/s0005-7967(03)00031-7.
- Zvolensky, M. J., Kotov, R., Bonn-Miller, M. O., Schmidt, N. B., & Antipova, A. V. (2008). Anxiety sensitivity as a moderator of association between smoking status and panic-related processes in a representative sample of adults. Journal of Psychiatric Research, 42(1), 69–77. https://pubmed.ncbi.nlm.nih.gov/17098257/ doi: 10.1016/j.jpsychires.2006.09.012.